Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Sexual Networks and Concurrency of Black and White MSM
Inhibition of VEGF Signaling Pathway and Metastasis
Psychosocial Aspects of Genetic Testing for Hnpcc
Isolation and Characterization of the Galanin Receptor
Cellular Analysis of Motor Development
Recently added grants:
Functional genetics of human innate immunity in the bimodal gamma delta T cell response to Epstein-Barr Virus and in education of NK cells and their re-education to respond to autologous cells
Deciphering the inositol phosphate code in viral pathogenesis and immunity
Approaches to Improve the Efficacy of Prime-boost Immunization against HIV/AIDS
Controlling the flux of sphingosine-1-phosphate in vivo
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35153-9-0-1
Application #
7579653
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/ University of Wisconsin Madison
$1,614,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bailey, Howard /
$1,058,141
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemoprevention Agents
/
Comments
Be the first to comment on this grant